Navigation Links
UCLA study finds robotic-assisted prostate surgery offers better cancer control
Date:2/28/2014

An observational study from UCLA's Jonsson Comprehensive Cancer Center has found that prostate cancer patients who undergo robotic-assisted prostate surgery have fewer instances of cancer cells at the edge of their surgical specimen and less need for additional cancer treatments like hormone or radiation therapy than patients who have traditional "open" surgery.

The study, published online Feb. 19 in the journal European Urology, was led by Dr. Jim Hu, UCLA's Henry E. Singleton Professor of Urology and director of robotic and minimally invasive surgery in the urology department at the David Geffen School of Medicine at UCLA.

Although it is becoming more popular, robotic-assisted radical prostatectomy the complete removal of the prostate using a robotic apparatus remains controversial because there has been little evidence that it provides better cancer control than open radical prostatectomy, the traditional surgical approach, which is less costly.

In an effort to determine whether or not robotic surgery offered an advantage, Hu and his colleagues compared 5,556 patients who received robotic surgery with 7,878 who underwent open surgery between 2004 and 2009. Data was provided by the Surveillance, Epidemiology, and End ResultsMedicare, a program of cancer registries that collect clinical and demographic information on people with cancer.

The researchers looked at the surgical margin status of the two groups, which is the amount of cancer cells at the edge of the removed prostate specimen. A positive margin the presence of cancer cells at the edge may result from cutting through the cancer and leaving some behind rather than cutting around the cancer completely. In prostate cancer, this has been shown to lead to a greater risk of recurrence and death from the disease.

The team also assessed the use of additional cancer therapies a hormone therapy known as androgen deprivation, as well as radiation
'/>"/>

Contact: Shaun Mason
smason@mednet.ucla.edu
310-206-2805
University of California - Los Angeles
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Study identifies possible new target for future brain cancer drugs
2. International study shows majority of children unaware of cigarette warning labels
3. UCSB study reveals evolution at work
4. Study reveals mechanisms cancer cells use to establish metastatic brain tumors
5. New study looks at biomarkers in assessing pitch counts bearing on injury
6. Study shows why breastfed babies are so smart
7. New study presents evidence that blood pressure should be measured in both arms
8. Study shows mentally ill more likely to be victims, not perpetrators, of violence
9. Study shows preventive ovarian surgery in BRCA1 mutation carriers should be performed early
10. Study finds differences in benefits, service at hospices based on tax status
11. Study shows that premature infants benefit from adult talk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 2014 AttorneyOne.com, a recognized authority on law, ... the FDA on Sit and Slim II . ... purchase or use Sit and Slim II because it contains ... promoted as weight loss product on various websites and possibly ... in 2010 for safety reasons, can significantly increase blood pressure ...
(Date:10/20/2014)... 2014 National Teen Driver Safety Week is ... Academy of Pediatrics (Ohio AAP, http://www.ohioaap.org ) is joining ... of teen drivers to talk to their teens and always ... vehicle crashes are the leading cause of death for U.S. ... fatal crashes, and 859 (42%) of those teen drivers were ...
(Date:10/20/2014)... Houston plastic surgeon Dr. Christopher Patronella ... innovative True Form Tummy Tuck® method as ... at The University of Texas Medical Branch in ... medical student. Patronella, who is a founding partner of ... in Texas, The Aesthetic Center for Plastic Surgery ...
(Date:10/19/2014)... New York (PRWEB) October 19, 2014 ... Nations Population Fund, welcomes news of a ceasefire agreement ... the more than 200 girls who were kidnapped from ... girls have languished in captivity long enough, and it ... schools and communities," stated Dr. Osotimehin. , "We owe ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 SweetDressy.com, a ... recently announced its promotion for long evening dresses ... enjoy the special offer; the current discount is up ... of the industry pioneers in the fashion field. Its ... for ladies dwelling in various parts of the world. ...
Breaking Medicine News(10 mins):Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Ohio AAP Promotes National Teen Driver Safety Week 2Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2Health News:Promotion For Beautiful Long Evening Dresses Launched By SweetDressy.com 2
... 2011 Studies show drinking V8 100% vegetable juice may be ... and may help them manage their weight two areas ... Guidelines for Americans. 1 A study conducted by ... drank one, 8-ounce glass of vegetable juice each day, as ...
... , THURSDAY, Feb. 3 (HealthDay News) -- Daily electronic ... doctors better understand the condition, a new study shows. ... digital assistant (PDA) device. The patients used their PDA ... issues three times a day for 30 days. ...
... DALLAS Feb. 3, 2011 UT Southwestern Medical ... a national network that conducts clinical trials aimed at ... 100 community treatment providers and academic medical centers throughout ... Institute on Drug Abuse,s Clinical Trials Network (CTN). The ...
... Feb. 2 (HealthDay News) -- Researchers report that DNA analysis ... rare vascular disease, along with its genetic cause. As ... England Journal of Medicine , the debilitating, painful and progressive ... the hands and feet of patients, and in the vascular ...
... By Kathleen Doheny HealthDay Reporter , WEDNESDAY, ... can help predict a daughter,s chances of not only having ... attack, new research shows. "Our new study shows that ... said Dr. Amitava Banerjee, a clinical research associate at the ...
... for ways to see dangerous blood clots before they ... School of Medicine in St. Louis report that they ... visible to a new kind of X-ray technology. ... cardiologist at Barnes-Jewish Hospital, these nanoparticles will take the ...
Cached Medicine News:Health News:Research suggests V8 100% vegetable juice can help people meet key dietary guidelines 2Health News:Researchers lead search for better drug-addiction treatments 2Health News:Scientists Discover Rare Vascular Disease 2Health News:If Mom Had a Stroke, Daughter May Be Prone to Heart Attack 2Health News:If Mom Had a Stroke, Daughter May Be Prone to Heart Attack 3Health News:New nanoparticles make blood clots visible 2Health News:New nanoparticles make blood clots visible 3
(Date:10/20/2014)... Oct. 20, 2014 Lpath, Inc. (NASDAQ: ... bioactive lipid-targeted therapeutics, received official notification from the European ... another key patent supporting its iSONEP™ and ASONEP™ ... European patent No. 2087002, claims compositions of matter ... two lead compounds, iSONEP and ASONEP. Sonepcizumab is ...
(Date:10/20/2014)... 20, 2014 Norgine B.V. today ... low volume bowel preparation, NER1006, presented at the 79 ... of Gastroenterology (ACG), Philadelphia, PA , ... weight and co-primary endpoint of cleansing success. The study ... MOVIPREP ® in screening colonoscopy patients. [1] ...
(Date:10/19/2014)... CTI BioPharma Corp. (CTI) (NASDAQ and MTA: ... quarter 2014 financial results on Wednesday, October 29, 2014, ... the announcement, members of the management team will host ... provide a general corporate update at 4:30 p.m. EDT ... obtained as follows: Wednesday, October 29 ...
Breaking Medicine Technology:Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 2Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 3Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 4Positive Results from Phase II Data Show NER1006 Achieves High Quality Bowel Cleansing Efficacy 2CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014 2
... Positive preclinical,data was presented by Nektar ... for its,lead oncolytic candidate, NKTR-102 (PEG-irinotecan), which ... model of colorectal,cancer when co-administered with bevacizumab. ... (AACR) Annual Meeting 2008 in San Diego,California, ...
... Kosan Biosciences,Incorporated (Nasdaq: KOSN ) today ... in patients with non-small cell lung cancer has ... multi-center, monotherapy,study of KOS-1584 in patients with measurable ... previously received only one prior,chemotherapy regimen. The primary ...
Cached Medicine Technology:Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting 2Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting 3Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting 4Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting 5Kosan Initiates Phase 2 Trial of Epothilone KOS-1584 in Non-Small Cell Lung Cancer 2Kosan Initiates Phase 2 Trial of Epothilone KOS-1584 in Non-Small Cell Lung Cancer 3Kosan Initiates Phase 2 Trial of Epothilone KOS-1584 in Non-Small Cell Lung Cancer 4
...
...
...
Conforms to the convexity of the lens providing easier access to anterior capsule. Reduces pontential of corneal touch. 35G x 5/8in (.50 x 16mm)...
Medicine Products: